These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 695447)

  • 21. Platelet and granulocyte pheresis.
    Sussman LN
    Ann Clin Lab Sci; 1978; 8(6):453-8. PubMed ID: 736509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The influence of initial values of donor platelets count on the efficiency of plateletpheresis with the cell separator Fenval Baxter Amicus s.v.2.51].
    Landzo E; Berbić-Fazlagić J; Sofo-Hafizović A
    Med Arh; 2009; 63(2):67-70. PubMed ID: 19537658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utilization of a new strength citrate anticoagulant during centrifugal plateletpheresis. I. Assessment of donor effects.
    Mishler JM; Janes AW; Lowes B; Farfan C; Emerson PM
    Br J Haematol; 1976 Nov; 34(3):387-94. PubMed ID: 990180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vivo and in vitro functional study of platelets obtained by pheresis with a semicontinuous flow cell separator].
    Cajozzo A; Citarrella P; Perricone R; Occhipinti G
    Riv Emoter Immunoematol; 1979; 26(1-2):73-9. PubMed ID: 554315
    [No Abstract]   [Full Text] [Related]  

  • 25. Implications of a switch to a 100% apheresis platelet supply for patients and for blood donors: a risk benefit analysis.
    Thiele T; Alt-Mayer T; Greinacher A; Bux J
    Vox Sang; 2016 Nov; 111(4):350-356. PubMed ID: 27432635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Which are the parameters to be controlled in platelet concentrates in order that they may be offered to the medical profession as a standardized product with specific properties?
    Vox Sang; 1981 Feb; 40(2):115-26. PubMed ID: 7233883
    [No Abstract]   [Full Text] [Related]  

  • 27. The effects of combined platelet and leukapheresis on the blood coagulation system.
    Kisker CT; Strauss RG; Koepke JA; Maguire LC; Thompson JS
    Transfusion; 1979; 19(2):173-7. PubMed ID: 432930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics and mobilization from the spleen of indium-111-labeled platelets during platelet apheresis.
    Heyns AD; Badenhorst PN; Lötter MG; Pieters H; Wessels P
    Transfusion; 1985; 25(3):215-8. PubMed ID: 4002306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of plateletpheresis on donor platelet function and coagulation.
    Akay OM; Akin E; Mutlu F; Gulbas Z
    Transfus Apher Sci; 2007 Oct; 37(2):113-4. PubMed ID: 17981089
    [No Abstract]   [Full Text] [Related]  

  • 30. Platelet activation during plasma-reduced multicomponent PLT collection: a comparison between COBE Trima and Spectra LRS turbo cell separators.
    Perseghin P; Mascaretti L; Speranza T; Belotti D; Baldini V; Dassi M; Riva M; Pogliani EM; Sciorelli G
    Transfusion; 2004 Jan; 44(1):125-30. PubMed ID: 14692978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet function testing during 5-day storage of single and random donor plateletpheresis.
    Akay OM; Gündüz E; Başyiğit H; Gulbas Z
    Transfus Apher Sci; 2007 Jun; 36(3):285-9. PubMed ID: 17602871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of platelets collected by semi-continuous flow centrifugation (Haemonetics Model 30).
    Slichter SJ
    Br J Haematol; 1978 Jan; 38(1):131-40. PubMed ID: 638058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet surface p-selectin, platelet-granulocyte heterotypic aggregates, and plasma-soluble p-selectin during plateletpheresis.
    Barnard MR; MacGregor H; Mercier R; Ragno G; Pivacek LE; Hechtman HB; Michelson AD; Valeri CR
    Transfusion; 1999 Jul; 39(7):735-41. PubMed ID: 10413281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary thrombocytopenia with excessively prolonged bleeding time, corrected by infusions of platelet poor plasma.
    Stavem P; Abrahamsen AF; Vartdal F; Nordhagen R; Rootwelt K
    Scand J Haematol; 1986 Sep; 37(3):210-4. PubMed ID: 3787172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in pre- and post-donation platelet function in plateletpheresis donors.
    Zhou Q; Yu X; Cai Y; Liu L
    Transfus Clin Biol; 2017 Nov; 24(4):417-421. PubMed ID: 28599950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-donor platelet concentrates stored in synthetic medium. In vitro and in vivo studies.
    Bertolini F; Marangoni F; Loy A; Marconi M; Almini D; Rebulla P; Sirchia G
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():135-8. PubMed ID: 8013972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of platelet density subpopulations in splenectomized mongrel dogs.
    Mezzano D; Aranda E; Foradori A; Rodríguez S; Lira P
    Am J Hematol; 1984; 17(4):373-82. PubMed ID: 6496460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term plateletpheresis in the management of primary thrombocytosis.
    Goldfinger D; Thompson R; Lowe C; Kurz L; Belkin G
    Transfusion; 1979; 19(3):336-8. PubMed ID: 452073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased ionized calcium during therapeutic plasma exchange pheresis and platelet pheresis.
    Morse EE; Hohnadel DC; Genco P; Katz AJ
    Johns Hopkins Med J; 1980 Jun; 146(6):260-3. PubMed ID: 7382251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.